ICD-10 Coding for Growth Hormone Deficiency(E23.0, E23.0B, E23.0H)
Comprehensive guide on ICD-10 coding for growth hormone deficiency, including documentation requirements, common pitfalls, and billing considerations.
Complete code families applicable to Growth Hormone Deficiency
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| E23.0 | Hypopituitarism | Use when there is confirmed hypopituitarism with failed GH stimulation tests. |
|
| E34.3 | Short stature due to endocrine disorder | Use when short stature is due to endocrine issues without confirmed pituitary cause. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutGrowth Hormone Deficiency
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Growth Hormone Deficiency.
Omitting GH test results in documentation
Impact
Clinical: May lead to misdiagnosis., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials.
Mitigation
Implement checklist for required documentation., Regular training on documentation standards.
Coding short stature without confirming pituitary dysfunction
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding standards., Data Quality: Inaccurate clinical data representation.
Mitigation
Ensure GH stimulation tests confirm hypopituitarism before using E23.0.
Documentation of GH test results
Impact
Lack of GH test results in documentation can trigger audits.
Mitigation
Ensure all GH test results are documented and easily accessible.